DKK1 and bladder transitional cell carcinoma: DKK1 levels, however, were substantially reduced in several cancers, including prostate adenocarcinoma (PRAD), kidney renal papillary cell carcinoma (KIRP), breast invasive carcinoma (BRCA), kidney chromophobe (KICH), and bladder urothelial carcinoma (BLCA).